Cerebral Therapeutics™ Names John Foster as President and Chief Operating Officer
Cerebral Therapeutics™, Inc. (Cerebral), a clinical-stage pharmaceutical company developing specialty medications for uncontrolled neurological diseases, announced today the appointment of industry veteran John Foster as President and Chief Operating Officer. Mr. Foster will utilize his extensive executive management experience leading companies, developing products and navigating the FDA regulatory environment to expand the strategic breadth and depth of the Cerebral executive management team.
